The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
Abstract
Context: GH excess causes an increase in bone turnover, but the consequences in terms of skeletal fragility have long been uncertain due to the heterogeneity of studies dealing with this topic. Objective: We conducted a meta-analysis of studies examining the effects of acromegaly on bone turnover, bone mineral density (BMD), and fractures. Furthermore, we evaluated the effects of sex, gonadal status, and activity of disease on skeletal end-points in acromegaly. Data Sources: We conducted MEDLINE and EMBASE systematic searches up to December 31, 2013. Study Eligibility Criteria: Studies conducted in patients with acromegaly and reporting at least one determinant of skeletal fragility. Data Extraction and Analysis: Study design, patient characteristics, interventions, and outcomes were independently extracted by two authors. We calculated the standardized mean difference (SMD) of bone turnover and BMD differences, whereas fractures were presented as relative frequencies in acromegaly and odds ratios between patients and controls. Results: Forty-one studies fulfilled eligibility criteria and were therefore selected for data extraction and analysis. A total of 1935 patients were included (eight to 206 per study). Acromegaly patients had higher bone formation (SMD, 1.49; 95% confidence interval [CI], 0.97–2.01; P < .0001) and bone resorption (SMD, 1.57; 95% CI, 1.03–2.10; P < .0001) as compared to control subjects, without significant differences in lumbar spine BMD. BMD at the femoral neck tended to be higher in acromegaly patients vs control subjects (SMD, 0.67; 95% CI, 0.07–1.27; P = .03). Patients with acromegaly had high frequency of vertebral fractures (odds ratio, 8.26; 95% CI, 2.91–23.39; P < .0001), in close relationship with male gender, hypogonadism, and active acromegaly. Limitations: Limitations included heterogeneous study protocols with possible variability in the assessment of skeletal end-points. Conclusions: Skeletal fragility is an emerging complication of acromegaly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study
Mazziotti, G., Bianchi, A., Porcelli, T., Mormando, M., Maffezzoni, F., Cristiano, A., Giampietro, A., De Marinis, L., & Giustina, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1460 · Cited by 172
Self-citationPrevalence of Vertebral Fractures in Men with Acromegaly
Mazziotti, G., Bianchi, A., Bonadonna, S., Cimino, V., Patelli, I., Fusco, A., Pontecorvi, A., De Marinis, L., & Giustina, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0791 · Cited by 169
Self-citationDiamond, T., Nery, L., & Posen, S. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-567 · Cited by 147 · cited 7×
“As a matter of fact, our meta-analysis showed a huge heterogeneity of literature data on this skeletal end-point, with only a few studies reporting low BMD in patients with acromegaly (10, 43), the others reporting instead either increased (9, 13, 17, 18, 41, 58) or similar (23, 44, 49, 52, 53) bone mass as compared t…”
BackgroundResultInfluentialWassenaar, M. J. E., Biermasz, N. R., Hamdy, N. A. T., Zillikens, M. C., van Meurs, J. B. J., Rivadeneira, F., Hofman, A., Uitterlinden, A. G., Stokkel, M. P. M., Roelfsema, F., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1005 · Cited by 144
Mazziotti, G., Bianchi, A., Bonadonna, S., Nuzzo, M., Cimino, V., Fusco, A., De Marinis, L., & Giustina, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060112 · Cited by 141
Self-citationMadeira, M., Neto, L. V., de Paula Paranhos Neto, F., Barbosa Lima, I. C., Carvalho de Mendonça, L. M., Gadelha, M. R., & Fleiuss de Farias, M. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4073 · Cited by 114 · cited 6×
“0 g/L in three studies (23, 58, 60), and suppressed GH values during oral glucose tolerance test in 23 studies (9, 17–21, 23, 24, 36– 39, 41, 45, 50–58).”
BackgroundInfluentialClaessen, K. M. J. A., Kroon, H. M., Pereira, A. M., Appelman-Dijkstra, N. M., Verstegen, M. J., Kloppenburg, M., Hamdy, N. A. T., & Biermasz, N. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2695 · Cited by 111
Bone mineral density and parameters of bone metabolism in patients with acromegaly
Kotzmann, H., Bernecker, P., Hübsch, P., Pietschmann, P., Woloszczuk, W., Svoboda, T., Geyer, G., & Luger, A. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080410 · Cited by 98
Bolanowski, M., Daroszewski, J., Mędraś, M., & Zadrożna-Śliwka, B. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0649-9 · Cited by 74 · cited 7×
“Patients with active acromegaly had a statistically significant higher bone formation (17, 34, 36, 38, 52, 55) (SMD, 1.”
BackgroundResultInfluentialUeland, T., Fougner, S. L., Godang, K., Schreiner, T., & Bollerslev, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02285 · Cited by 69
Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status
Scillitani, A., Battista, C., Chiodini, I., Carnevale, V., Fusilli, S., Ciccarelli, E., Terzolo, M., Oppizzi, G., Arosio, M., Gasperi, M., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01777.x · Cited by 63
Axial bone mineral density in patients with acromegaly
Bolanowski, M., Wielgus, W., Milewicz, A., & Marciniak, R. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80573-5 · Cited by 25 · cited 3×
“As a matter of fact, our meta-analysis showed a huge heterogeneity of literature data on this skeletal end-point, with only a few studies reporting low BMD in patients with acromegaly (10, 43), the others reporting instead either increased (9, 13, 17, 18, 41, 58) or similar (23, 44, 49, 52, 53) bone mass as compared t…”
BackgroundResultVarious risks of osteoporosis in patients with pituitary adenomas
Matsuyama, J., Eshima, N., Fukunaga, T., Hori, S., Kobayashi, H., & Isono, M. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740300015 · Cited by 14
Cited by
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Self-citationA Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Giustina, A., Barkan, A., Beckers, A., Biermasz, N., Biller, B. M. K., Boguszewski, C., Bolanowski, M., Bonert, V., Bronstein, M. D., Casanueva, F. F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz096 · Cited by 371
Self-citationSystemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Self-citation
Metadata
- Authors
- Mazziotti, G., Biagioli, E., Maffezzoni, F., Spinello, M., Serra, V., Maroldi, R., Floriani, I., & Giustina, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-02-01
- Volume
- 100
- Issue
- 2
- Pages
- 384-394
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096131890
- Cited by
- 183
- References
- 15
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.